Logo image of CRL.MI

CAREL INDUSTRIES SPA (CRL.MI) Stock Fundamental Analysis

BIT:CRL - Euronext Milan - IT0005331019 - Common Stock - Currency: EUR

23.95  +1.45 (+6.44%)

Fundamental Rating

5

Overall CRL gets a fundamental rating of 5 out of 10. We evaluated CRL against 20 industry peers in the Building Products industry. CRL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CRL is quite expensive at the moment. It does show a decent growth rate. This makes CRL very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRL was profitable.
CRL had a positive operating cash flow in the past year.
CRL had positive earnings in each of the past 5 years.
Each year in the past 5 years CRL had a positive operating cash flow.
CRL.MI Yearly Net Income VS EBIT VS OCF VS FCFCRL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

CRL's Return On Assets of 6.55% is amongst the best of the industry. CRL outperforms 85.00% of its industry peers.
The Return On Equity of CRL (12.78%) is better than 75.00% of its industry peers.
With a Return On Invested Capital value of 7.65%, CRL perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
CRL had an Average Return On Invested Capital over the past 3 years of 11.78%. This is above the industry average of 9.15%.
The last Return On Invested Capital (7.65%) for CRL is well below the 3 year average (11.78%), which needs to be investigated, but indicates that CRL had better years and this may not be a problem.
Industry RankSector Rank
ROA 6.55%
ROE 12.78%
ROIC 7.65%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
CRL.MI Yearly ROA, ROE, ROICCRL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

CRL has a better Profit Margin (9.71%) than 90.00% of its industry peers.
In the last couple of years the Profit Margin of CRL has remained more or less at the same level.
Looking at the Operating Margin, with a value of 11.19%, CRL belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CRL has declined.
CRL has a Gross Margin (45.15%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CRL has grown nicely.
Industry RankSector Rank
OM 11.19%
PM (TTM) 9.71%
GM 45.15%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
CRL.MI Yearly Profit, Operating, Gross MarginsCRL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRL is creating some value.
The number of shares outstanding for CRL remains at a similar level compared to 1 year ago.
The number of shares outstanding for CRL has been increased compared to 5 years ago.
The debt/assets ratio for CRL has been reduced compared to a year ago.
CRL.MI Yearly Shares OutstandingCRL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CRL.MI Yearly Total Debt VS Total AssetsCRL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 5.48 indicates that CRL is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.48, CRL belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
The Debt to FCF ratio of CRL is 2.55, which is a good value as it means it would take CRL, 2.55 years of fcf income to pay off all of its debts.
CRL's Debt to FCF ratio of 2.55 is amongst the best of the industry. CRL outperforms 85.00% of its industry peers.
CRL has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CRL (0.23) is better than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 2.55
Altman-Z 5.48
ROIC/WACC0.97
WACC7.88%
CRL.MI Yearly LT Debt VS Equity VS FCFCRL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.85 indicates that CRL should not have too much problems paying its short term obligations.
The Current ratio of CRL (1.85) is better than 75.00% of its industry peers.
CRL has a Quick Ratio of 1.32. This is a normal value and indicates that CRL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.32, CRL is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.32
CRL.MI Yearly Current Assets VS Current LiabilitesCRL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for CRL have decreased strongly by -19.15% in the last year.
The Earnings Per Share has been growing by 9.70% on average over the past years. This is quite good.
Looking at the last year, CRL shows a decrease in Revenue. The Revenue has decreased by -8.83% in the last year.
CRL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.06% yearly.
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%-40%
Revenue 1Y (TTM)-8.83%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%0.67%

3.2 Future

Based on estimates for the next years, CRL will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.88% on average per year.
The Revenue is expected to grow by 8.38% on average over the next years. This is quite good.
EPS Next Y-1.98%
EPS Next 2Y8.48%
EPS Next 3Y11.88%
EPS Next 5YN/A
Revenue Next Year7.8%
Revenue Next 2Y8.36%
Revenue Next 3Y8.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRL.MI Yearly Revenue VS EstimatesCRL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CRL.MI Yearly EPS VS EstimatesCRL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 42.77, which means the current valuation is very expensive for CRL.
CRL's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.45, CRL is valued quite expensively.
Based on the Price/Forward Earnings ratio of 36.34, the valuation of CRL can be described as expensive.
65.00% of the companies in the same industry are cheaper than CRL, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.90. CRL is valued rather expensively when compared to this.
Industry RankSector Rank
PE 42.77
Fwd PE 36.34
CRL.MI Price Earnings VS Forward Price EarningsCRL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRL indicates a rather expensive valuation: CRL more expensive than 80.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CRL is valued a bit more expensive than the industry average as 65.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 44.82
EV/EBITDA 24.53
CRL.MI Per share dataCRL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

CRL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.41
EPS Next 2Y8.48%
EPS Next 3Y11.88%

3

5. Dividend

5.1 Amount

CRL has a yearly dividend return of 0.74%, which is pretty low.
CRL's Dividend Yield is slightly below the industry average, which is at 4.16.
With a Dividend Yield of 0.74, CRL pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.74%

5.2 History

The dividend of CRL is nicely growing with an annual growth rate of 14.04%!
Dividend Growth(5Y)14.04%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CRL pays out 38.00% of its income as dividend. This is a sustainable payout ratio.
CRL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP38%
EPS Next 2Y8.48%
EPS Next 3Y11.88%
CRL.MI Yearly Income VS Free CF VS DividendCRL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRL.MI Dividend Payout.CRL.MI Dividend Payout, showing the Payout Ratio.CRL.MI Dividend Payout.PayoutRetained Earnings

CAREL INDUSTRIES SPA

BIT:CRL (7/3/2025, 7:00:00 PM)

23.95

+1.45 (+6.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-01 2025-08-01
Inst Owners28.06%
Inst Owner ChangeN/A
Ins Owners52.75%
Ins Owner ChangeN/A
Market Cap2.69B
Analysts71.11
Price Target21.17 (-11.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.74%
Yearly Dividend0.19
Dividend Growth(5Y)14.04%
DP38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.56%
Min Revenue beat(2)-5.31%
Max Revenue beat(2)-1.82%
Revenue beat(4)0
Avg Revenue beat(4)-4.19%
Min Revenue beat(4)-5.31%
Max Revenue beat(4)-1.82%
Revenue beat(8)3
Avg Revenue beat(8)-2.67%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.96%
PT rev (3m)6.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.73%
Valuation
Industry RankSector Rank
PE 42.77
Fwd PE 36.34
P/S 4.65
P/FCF 44.82
P/OCF 29.7
P/B 6.12
P/tB 41.76
EV/EBITDA 24.53
EPS(TTM)0.56
EY2.34%
EPS(NY)0.66
Fwd EY2.75%
FCF(TTM)0.53
FCFY2.23%
OCF(TTM)0.81
OCFY3.37%
SpS5.15
BVpS3.91
TBVpS0.57
PEG (NY)N/A
PEG (5Y)4.41
Profitability
Industry RankSector Rank
ROA 6.55%
ROE 12.78%
ROCE 9.61%
ROIC 7.65%
ROICexc 9.13%
ROICexgc 27.19%
OM 11.19%
PM (TTM) 9.71%
GM 45.15%
FCFM 10.37%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
ROICexc(3y)15.05%
ROICexc(5y)17.4%
ROICexgc(3y)43.53%
ROICexgc(5y)43.91%
ROCE(3y)14.8%
ROCE(5y)15.83%
ROICexcg growth 3Y-17.51%
ROICexcg growth 5Y-0.61%
ROICexc growth 3Y-24.29%
ROICexc growth 5Y-10.93%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 2.55
Debt/EBITDA 0.95
Cap/Depr 76.48%
Cap/Sales 5.28%
Interest Coverage 18.94
Cash Conversion 86.54%
Profit Quality 106.89%
Current Ratio 1.85
Quick Ratio 1.32
Altman-Z 5.48
F-Score5
WACC7.88%
ROIC/WACC0.97
Cap/Depr(3y)91.98%
Cap/Depr(5y)87.52%
Cap/Sales(3y)4.87%
Cap/Sales(5y)4.61%
Profit Quality(3y)86.55%
Profit Quality(5y)91.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%-40%
EPS Next Y-1.98%
EPS Next 2Y8.48%
EPS Next 3Y11.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.83%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%0.67%
Revenue Next Year7.8%
Revenue Next 2Y8.36%
Revenue Next 3Y8.38%
Revenue Next 5YN/A
EBIT growth 1Y-32.22%
EBIT growth 3Y1.26%
EBIT growth 5Y7.88%
EBIT Next Year83.59%
EBIT Next 3Y32.38%
EBIT Next 5YN/A
FCF growth 1Y13.76%
FCF growth 3Y14.88%
FCF growth 5Y15.64%
OCF growth 1Y16.29%
OCF growth 3Y16.42%
OCF growth 5Y11.49%